Table 1.

Positive markers found in the analyses using classification and regression trees

Chr	Marker	Marker Alias	Position	Previous Reports
1	D1S1665	GATA61A06	1p31.1	Amylase, salivary, Pancreatic (1p21), facilitated glucose transporter (1p31-35), agiopoietin-like 3 (1p31)
2	D2S2952	GATA116B01	2p25.1	Glucokinase regulatory protein (2p23), Alstrom syndrome (2p13), serum levels of leptin (2p21), hexokinase 2 (2p12), eukaryote translation initiation factor 2-α kinase 3 (Wolcott-Rallison syndrome, 2p21)
6	D6S474	GATA31	6q21	IDDM 1 (6q21) IDDM5 (6q24-27), IDDM8 (6q25-27), IDDM15, transient neonatal diabetes mellitus (6q24), pleomorphic adenoma gene-like 1 (6q24-26), phosphodiesterase 1 (6q22-23)
11	D11S1981	GATA48E02	11p15.1	HRAS (11p14.1), INS (11p14.1), MODY1 (11p15.5), phosphodiesterase 3B (11p15), SUR1 (11p15.1), Kir6.2 (11p15.1)
16	D16S3396	ATA55A11	16q12.1	RRAD (16q22)
	D16S3253	GATA22F09	16q12.2
	D16S2620	GATA67G11
18	D18S542	GATA11A06	18p11.21
19	D19S254	Mfd238	19q13.43	Glycogen synthase 1 (muscle)(19q13.3), ApoCIII (19q13.2), Dystrophia Myotonica 1 (19q13.2-13.3), AKT2 (19q13.1-13.2), TGFβ1 (19q13.1), Glycogen synthase kinase 3A (19q13.1-13.2)